Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

OptimizeRx (OPRX) Non Operating Income (2016 - 2025)

OptimizeRx's Non Operating Income history spans 16 years, with the latest figure at -$999000.0 for Q3 2025.

  • For Q3 2025, Non Operating Income rose 27.56% year-over-year to -$999000.0; the TTM value through Sep 2025 reached -$5.1 million, changed 0.33%, while the annual FY2024 figure was -$5.7 million, 558.72% down from the prior year.
  • Non Operating Income for Q3 2025 was -$999000.0 at OptimizeRx, up from -$1.5 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $721000.0 in Q2 2023 and bottomed at -$1.5 million in Q1 2024.
  • The 5-year median for Non Operating Income is $931.0 (2021), against an average of -$379774.9.
  • The largest annual shift saw Non Operating Income surged 22166566.67% in 2023 before it tumbled 329.47% in 2024.
  • A 5-year view of Non Operating Income shows it stood at $2382.0 in 2021, then skyrocketed by 22507.51% to $538511.0 in 2022, then plummeted by 255.24% to -$836000.0 in 2023, then plummeted by 70.57% to -$1.4 million in 2024, then increased by 29.94% to -$999000.0 in 2025.
  • Per Business Quant, the three most recent readings for OPRX's Non Operating Income are -$999000.0 (Q3 2025), -$1.5 million (Q2 2025), and -$1.2 million (Q1 2025).